• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组鉴定小细胞肺癌中扩增和/或融合的基因。

Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer.

机构信息

Division of Multistep Carcinogenesis, National Cancer Center Research Institute, Tokyo 104-0045, Japan.

出版信息

Genes Chromosomes Cancer. 2013 Sep;52(9):802-16. doi: 10.1002/gcc.22076. Epub 2013 May 28.

DOI:10.1002/gcc.22076
PMID:23716474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3806277/
Abstract

To obtain a landscape of gross genetic alterations in small cell lung cancer (SCLC), genome-wide copy number analysis and whole-transcriptome sequencing were performed in 58 and 42 SCLCs, respectively. Focal amplification of known oncogene loci, MYCL1 (1p34.2), MYCN (2p24.3), and MYC (8q24.21), was frequently and mutually exclusively detected. MYCL1 and MYC were co-amplified with other regions on either the same or the different chromosome in several cases. In addition, the 9p24.1 region was identified as being amplified in SCLCs without amplification of MYC family oncogenes. Notably, expression of the KIAA1432 gene in this region was significantly higher in KIAA1432 amplified cells than in non-amplified cells, and its mRNA expression showed strong correlations with the copy numbers. Thus, KIAA1432 is a novel gene activated by amplification in SCLCs. By whole-transcriptome sequencing, a total of 60 fusion transcripts, transcribed from 95 different genes, were identified as being expressed in SCLC cells. However, no in-frame fusion transcripts were recurrently detected in ≥2 SCLCs, and genes in the amplified regions, such as PVT1 neighboring MYC and RLF in MYCL1 amplicons, were recurrently fused with genes in the same amplicons or with those in different amplicons on either the same or different chromosome. Thus, it was indicated that amplification and fusion of several genes on chromosomes 1 and 8 occur simultaneously but not sequentially through chromothripsis in the development of SCLC, and amplification rather than fusion of genes plays an important role in its development.

摘要

为了获得小细胞肺癌(SCLC)的总体遗传改变图谱,分别对 58 例和 42 例 SCLC 进行了全基因组拷贝数分析和全转录组测序。频繁且相互排斥地检测到已知癌基因座 MYCL1(1p34.2)、MYCN(2p24.3)和 MYC(8q24.21)的局灶性扩增。在几种情况下,MYCL1 和 MYC 与同一或不同染色体上的其他区域同时或分别被扩增。此外,9p24.1 区域被鉴定为在没有 MYC 家族癌基因扩增的 SCLC 中被扩增。值得注意的是,该区域中 KIAA1432 基因的表达在 KIAA1432 扩增细胞中明显高于非扩增细胞,其 mRNA 表达与拷贝数呈强相关性。因此,KIAA1432 是 SCLC 中扩增激活的一个新基因。通过全转录组测序,总共鉴定出 60 个融合转录本,由 95 个不同的基因转录而来,这些转录本在 SCLC 细胞中表达。然而,没有在≥2 例 SCLC 中反复检测到框架内融合转录本,并且在扩增区域中的基因,如 MYC 附近的 PVT1 和 MYCL1 扩增子中的 RLF,与相同扩增子或同一或不同染色体上不同扩增子中的基因反复融合。因此,这表明在 SCLC 的发展过程中,染色体 1 和 8 上的几个基因的扩增和融合是同时发生的,而不是通过染色体重排依次发生的,并且基因的扩增而不是融合在其发展中起着重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/c15cd6e0ac53/gcc0052-0802-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/3d21cccb5fd6/gcc0052-0802-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/3449ef3760ec/gcc0052-0802-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/c15cd6e0ac53/gcc0052-0802-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/3d21cccb5fd6/gcc0052-0802-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/3449ef3760ec/gcc0052-0802-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99e/3806277/c15cd6e0ac53/gcc0052-0802-f3.jpg

相似文献

1
Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer.全基因组鉴定小细胞肺癌中扩增和/或融合的基因。
Genes Chromosomes Cancer. 2013 Sep;52(9):802-16. doi: 10.1002/gcc.22076. Epub 2013 May 28.
2
Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.小细胞肺癌的联合微阵列分析揭示了凋亡平衡的改变以及MYC家族基因扩增的独特表达特征。
Oncogene. 2006 Jan 5;25(1):130-8. doi: 10.1038/sj.onc.1208997.
3
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.全面的基因组分析确定 SOX2 是小细胞肺癌中经常扩增的基因。
Nat Genet. 2012 Oct;44(10):1111-6. doi: 10.1038/ng.2405. Epub 2012 Sep 2.
4
MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma.MYCL1 扩增及 L-Myc 和 c-Myc 在手术切除的小细胞肺癌中的表达。
Pathol Oncol Res. 2021 Jun 18;27:1609775. doi: 10.3389/pore.2021.1609775. eCollection 2021.
5
Identification and functional analysis of 9p24 amplified genes in human breast cancer.鉴定和功能分析 9p24 扩增基因在人类乳腺癌。
Oncogene. 2012 Jan 19;31(3):333-41. doi: 10.1038/onc.2011.227. Epub 2011 Jun 13.
6
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.L-myc,一种在人类小细胞肺癌中扩增并表达的新的与myc相关的基因。
Nature. 1985;318(6041):69-73. doi: 10.1038/318069a0.
7
Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.原发性肺癌中L-myc和rlf的重排及共扩增
Oncogene. 1992 Mar;7(3):405-9.
8
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer.环状PVT1和PVT1/AKT3在小细胞肺癌的细胞增殖、凋亡及肿瘤亚型定义中发挥作用。
Genes Chromosomes Cancer. 2023 Jul;62(7):377-391. doi: 10.1002/gcc.23121. Epub 2023 Jan 23.
9
Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer.小细胞肺癌中L-myc基因扩增过程中的复杂染色体内重排
Mol Cell Biol. 1992 Apr;12(4):1747-54. doi: 10.1128/mcb.12.4.1747-1754.1992.
10
Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line.联合染色体显微切割和比较基因组杂交检测人肺癌细胞系中多个DNA扩增位点。
Genes Chromosomes Cancer. 1997 Oct;20(2):208-12. doi: 10.1002/(sici)1098-2264(199710)20:2<208::aid-gcc13>3.0.co;2-m.

引用本文的文献

1
Non-Coding RNAs in Asthma: Regulators of Eosinophil Biology and Airway Inflammation.哮喘中的非编码RNA:嗜酸性粒细胞生物学和气道炎症的调节因子
Diagnostics (Basel). 2025 Jul 10;15(14):1750. doi: 10.3390/diagnostics15141750.
2
Cancer cells' chamber of secrets: the link between micronuclei, chromothripsis and malignancy.癌细胞的秘密之室:微核、染色体碎裂与恶性肿瘤之间的联系
Open Biol. 2025 May;15(5):240388. doi: 10.1098/rsob.240388. Epub 2025 May 14.
3
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer.

本文引用的文献

1
A framework for identification of actionable cancer genome dependencies in small cell lung cancer.用于鉴定小细胞肺癌中可操作的癌症基因组依赖性的框架。
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17034-9. doi: 10.1073/pnas.1207310109. Epub 2012 Oct 3.
2
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.全面的基因组分析确定 SOX2 是小细胞肺癌中经常扩增的基因。
Nat Genet. 2012 Oct;44(10):1111-6. doi: 10.1038/ng.2405. Epub 2012 Sep 2.
3
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
Polo样激酶1抑制剂在小细胞肺癌临床前模型中显示出体外和体内疗效。
Cancers (Basel). 2025 Jan 28;17(3):446. doi: 10.3390/cancers17030446.
4
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics.小细胞肺癌治疗的临床转化研究新进展
Cancers (Basel). 2025 Jan 14;17(2):255. doi: 10.3390/cancers17020255.
5
Unveiling the Mechanism of Lurbinectedin's Action and Its Potential in Combination Therapies in Small Cell Lung Cancer.揭示鲁比卡丁的作用机制及其在小细胞肺癌联合治疗中的潜力。
Mol Cancer Ther. 2025 Jun 4;24(6):828-839. doi: 10.1158/1535-7163.MCT-24-0050.
6
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.小细胞肺癌分子特征和治疗靶点的新进展。
Nat Rev Clin Oncol. 2024 Aug;21(8):610-627. doi: 10.1038/s41571-024-00914-x. Epub 2024 Jul 4.
7
Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer.突破范式:形成基因融合的长链非编码RNA及其在癌症中的潜在意义
Genes Dis. 2023 Oct 11;11(3):101136. doi: 10.1016/j.gendis.2023.101136. eCollection 2024 May.
8
Advancements in Focal Amplification Detection in Tumor/Liquid Biopsies and Emerging Clinical Applications.肿瘤/液体活检中焦点扩增检测的进展和新兴临床应用。
Genes (Basel). 2023 Jun 20;14(6):1304. doi: 10.3390/genes14061304.
9
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.染色体外 DNA 扩增导致小细胞肺癌异质性并与更差的预后相关。
Cancer Discov. 2023 Apr 3;13(4):928-949. doi: 10.1158/2159-8290.CD-22-0796.
10
DNA Methylation Changes in Autologous Hematopoietic Stem Cell Transplant Patients.自体造血干细胞移植患者的 DNA 甲基化变化。
Biol Res Nurs. 2023 Apr;25(2):310-325. doi: 10.1177/10998004221135628. Epub 2022 Nov 2.
综合性基因组分析鉴定出小细胞肺癌的重要体细胞驱动突变。
Nat Genet. 2012 Oct;44(10):1104-10. doi: 10.1038/ng.2396. Epub 2012 Sep 2.
4
Subgroup-specific structural variation across 1,000 medulloblastoma genomes.1000 例髓母细胞瘤全基因组亚组特异性结构变异。
Nature. 2012 Aug 2;488(7409):49-56. doi: 10.1038/nature11327.
5
KIF5B-RET fusions in lung adenocarcinoma.肺腺癌中的 KIF5B-RET 融合。
Nat Med. 2012 Feb 12;18(3):375-7. doi: 10.1038/nm.2644.
6
Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.鉴定 ALK 阳性和 EGFR/KRAS/ALK 阴性肺腺癌中上调的基因。
Cancer Res. 2012 Jan 1;72(1):100-11. doi: 10.1158/0008-5472.CAN-11-1403. Epub 2011 Nov 11.
7
Molecular biology of lung cancer: clinical implications.肺癌的分子生物学:临床意义。
Clin Chest Med. 2011 Dec;32(4):703-40. doi: 10.1016/j.ccm.2011.08.003. Epub 2011 Oct 7.
8
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.BET 溴结构域抑制作为靶向 c-Myc 的治疗策略。
Cell. 2011 Sep 16;146(6):904-17. doi: 10.1016/j.cell.2011.08.017. Epub 2011 Sep 1.
9
Nuclear factor I/B is an oncogene in small cell lung cancer.核因子 I/B 是小细胞肺癌中的一种癌基因。
Genes Dev. 2011 Jul 15;25(14):1470-5. doi: 10.1101/gad.2046711.
10
Identification and functional analysis of 9p24 amplified genes in human breast cancer.鉴定和功能分析 9p24 扩增基因在人类乳腺癌。
Oncogene. 2012 Jan 19;31(3):333-41. doi: 10.1038/onc.2011.227. Epub 2011 Jun 13.